Ophthalmology

Vision Innovation Partners is a company providing management and support services to the leading comprehensive eye care providers in states across the Mid-Atlantic Region. Here are seven facts about the growing company, according to its website:

Watchmaker Omega has renewed its partnership with eye care nonprofit Orbis International for another five years, pledging $2.5 million in support to the eye care provider.

Atlanta-based EyeSouth Partners has affiliated with Pittsburgh-based North Park Ophthalmology.

Clinical trial research organization Parexel has partnered with vision healthcare organization MyEyeDr to collaborate on recruitment for diabetic retinopathy and macular degeneration clinical trials. 

ASC and ophthalmology management services organization Sunvera Group has partnered with Mentor, Ohio-based Ophthalmic Physicians Incorporated and its affiliates. 

Nashville, Tenn.-based eyecare pharmaceutical company Harrow has acquired the U.S. commercial rights to five FDA-approved ophthalmic medications from Novartis for $175 million. 

Clinical trial management company Vial has added retina specialist Veeral Sheth, MD, to its scientific advisory board. 

Private equity-backed ophthalmology services provider Vision Innovation Partners has completed four practice acquisitions in 2022, bringing its total number of practices to 24.

Vision Innovation Partners inked a partnership with Chesen Laser Eye Center in Reading, Pa.

Cumming Ophthalmic Research and Development has filed an application for premarket approval with the U.S. Food and Drug Administration for a lens to help treat cataracts.